verily google health south san francisco california treatments shown combat covid-19 rigorous clinical trials convalescent plasma tested small trials statistical power provide firm conclusions fda not respond queries things stand decision authorize convalescent plasma fda issues authorization experts people covid-19 choose access treatment directly sign clinical trial risk assigned control group not receive plasma potential therapy work not think bounds available authorization says califf ought emphasizing public service announcements participation randomized trials priority century doctors convalescent plasma donors recovering infections treat disease including ebola middle east respiratory syndrome mers caused coronavirus idea plasma contains antibodies proteins involved regulating immune responses